πŸ‡ΊπŸ‡Έ FDA
Patent

US 9140687

Renal cell carcinoma biomarkers

granted A61PA61P35/00

Quick answer

US patent 9140687 (Renal cell carcinoma biomarkers) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P35/00